Table of contents
Volume 90, Issue 5
Published online 2 March 2004 (941-1110)
Clinical |
Short Communications |
Epidemiology |
Molecular and Cellular Pathology |
Experimental Therapeutics |
Letters to the Editor
Minireviews
Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? FREE
E S Schernhammer and K Schulmeister
Br J Cancer 90: 941-943; doi:10.1038/sj.bjc.6601626
Targeting oestrogen to kill the cancer but not the patient FREE
J S Lewis, D Cheng and V C Jordan
Br J Cancer 90: 944-949; doi:10.1038/sj.bjc.6601627
The use of hormonal therapy with radiotherapy for prostate cancer: analysis of prospective randomised trials FREE
A R Gottschalk and M Roach III
Br J Cancer 90: 950-954; doi:10.1038/sj.bjc.6601625
Clinical
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers FREE
J B Bartlett, A Michael, I A Clarke, K Dredge, S Nicholson, H Kristeleit, A Polychronis, H Pandha, G W Muller, D I Stirling, J Zeldis and A G Dalgleish
Br J Cancer 90: 955-961; doi:10.1038/sj.bjc.6601579
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy FREE
A Gennari, P Bruzzi, C Orlandini, B Salvadori, S Donati, E Landucci, V Guarneri, M Rondini, S Ricci and P Conte
Br J Cancer 90: 962-967; doi:10.1038/sj.bjc.6601634
Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients FREE
A A Ezzat, E M Ibrahim, D S Ajarim, M M Rahal, M A Raja, A M Tulbah, O A Al-Malik, M Al-Shabanah and R Sorbris
Br J Cancer 90: 968-974; doi:10.1038/sj.bjc.6601616
Management of low-grade squamous intraepithelial lesions of the uterine cervix FREE
C Scheungraber, N Kleekamp and A Schneider
Br J Cancer 90: 975-978; doi:10.1038/sj.bjc.6601415
Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer FREE
H Katayama, H Ueoka, K Kiura, M Tabata, T Kozuki, M Tanimoto, T Fujiwara, N Tanaka, H Date, M Aoe, N Shimizu, M Takemoto and Y Hiraki
Br J Cancer 90: 979-984; doi:10.1038/sj.bjc.6601624
A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients FREE
I Bleumer, A Knuth, E Oosterwijk, R Hofmann, Z Varga, C Lamers, W Kruit, S Melchior, C Mala, S Ullrich, P De Mulder, P F A Mulders and J Beck
Br J Cancer 90: 985-990; doi:10.1038/sj.bjc.6601617
Rounding of low serum creatinine levels and consequent impact on accuracy of bedside estimates of renal function in cancer patients FREE
M J Dooley, S Singh and D Rischin
Br J Cancer 90: 991-995; doi:10.1038/sj.bjc.6601641
Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids FREE
A W G Moses, C Slater, T Preston, M D Barber and K C H Fearon
Br J Cancer 90: 996-1002; doi:10.1038/sj.bjc.6601620
Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study FREE
S Ohwada, T Ikeya, T Yokomori, T Kusaba, T Roppongi, T Takahashi, S Nakamura, S Kakinuma, S Iwazaki, H Ishikawa, S Kawate, T Nakajima and Y Morishita
Br J Cancer 90: 1003-1010; doi:10.1038/sj.bjc.6601619
Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration FREE
G Garcea, D J L Jones, R Singh, A R Dennison, P B Farmer, R A Sharma, W P Steward, A J Gescher and D P Berry
Br J Cancer 90: 1011-1015; doi:10.1038/sj.bjc.6601623
Short Communications
Parental cigarette smoking and childhood risks of hepatoblastoma: OSCC data FREE
T Sorahan and R J Lancashire
Br J Cancer 90: 1016-1018; doi:10.1038/sj.bjc.6601651
Trends in mortality for cancers, comparing multiple- and underlying-cause rates, in an English population 1979–1999 FREE
M J Goldacre, M E Duncan, P Cook-Mozaffari and M Griffith
Br J Cancer 90: 1019-1021; doi:10.1038/sj.bjc.6601633
The Mesothelioma epidemic in Western Europe: an update FREE
C Pelucchi, M Malvezzi, C La Vecchia, F Levi, A Decarli and E Negri
Br J Cancer 90: 1022-1024; doi:10.1038/sj.bjc.6601638
Epidemiology
A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland FREE
M Hinkula, E Pukkala, P Kyyrönen, P Laukkanen, P Koskela, J Paavonen, M Lehtinen and A Kauppila
Br J Cancer 90: 1025-1029; doi:10.1038/sj.bjc.6601650
Molecular and Cellular Pathology
CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer FREE
K Hibi, H Nakayama, Y Kodera, K Ito, S Akiyama and A Nakao
Br J Cancer 90: 1030-1033; doi:10.1038/sj.bjc.6601647
Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein FREE
A Kiessling, S Stevanovic, S Füssel, B Weigle, M A Rieger, A Temme, E P Rieber and M Schmitz
Br J Cancer 90: 1034-1040; doi:10.1038/sj.bjc.6601642
Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer FREE
K J Savinainen, M J Linja, O R Saramäki, T L J Tammela, G T G Chang, A O Brinkmann and T Visakorpi
Br J Cancer 90: 1041-1046; doi:10.1038/sj.bjc.6601648
ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours FREE
S Vicent, J M López-Picazo, G Toledo, M D Lozano, W Torre, C Garcia-Corchón, C Quero, J-C Soria, S Martín-Algarra, R G Manzano and L M Montuenga
Br J Cancer 90: 1047-1052; doi:10.1038/sj.bjc.6601644
ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma FREE
R Grützmann, J Lüttges, B Sipos, O Ammerpohl, F Dobrowolski, I Alldinger, S Kersting, D Ockert, R Koch, H Kalthoff, H K Schackert, H D Saeger, G Klöppel and C Pilarsky
Br J Cancer 90: 1053-1058; doi:10.1038/sj.bjc.6601645
Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma FREE
L Juillerat-Jeanneret, J Celerier, C Chapuis Bernasconi, G Nguyen, W Wostl, H P Maerki, R-C Janzer, P Corvol and J-M Gasc
Br J Cancer 90: 1059-1068; doi:10.1038/sj.bjc.6601646
Experimental Therapeutics
Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells FREE
H Takeuchi, T Kanzawa, Y Kondo and S Kondo
Br J Cancer 90: 1069-1075; doi:10.1038/sj.bjc.6601605
Specific roles for the PI3K and the MEK–ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model FREE
E Menu, R Kooijman, E Van Valckenborgh, K Asosingh, M Bakkus, B Van Camp and K Vanderkerken
Br J Cancer 90: 1076-1083; doi:10.1038/sj.bjc.6601613
2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT FREE
N A Helsby, D M Ferry, A V Patterson, S M Pullen and W R Wilson
Br J Cancer 90: 1084-1092; doi:10.1038/sj.bjc.6601612
Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs FREE
S Li, E Hanna, R Breau, V Ratanatharathorn, X Xia and J Suen
Br J Cancer 90: 1093-1099; doi:10.1038/sj.bjc.6601636
Selective disruption of the E-cadherin–catenin system by an algal toxin FREE
G Ronzitti, F Callegari, C Malaguti and G P Rossini
Br J Cancer 90: 1100-1107; doi:10.1038/sj.bjc.6601640
Letters to the Editor
The value of cervical screening to young women FREE
A Herbert
Br J Cancer 90: 1108; doi:10.1038/sj.bjc.6601596
Reply: The value of case—control audits of screening FREE
P Sasieni, J Adams and J Cuzick
Br J Cancer 90: 1109-1110; doi:10.1038/sj.bjc.6601599
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
